162 related articles for article (PubMed ID: 36735596)
1. Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program.
Garvey WT; Cheng M; Ramasamy A; Smolarz BG; Park S; Kumar N; Kim N; DerSarkissian M; Bhak RH; Duh MS; Wu M; Hansen S; Young-Xu Y
Popul Health Manag; 2023 Feb; 26(1):72-82. PubMed ID: 36735596
[No Abstract] [Full Text] [Related]
2. Observational Comparative Effectiveness of Pharmaceutical Treatments for Obesity within the Veterans Health Administration.
Grabarczyk TR
Pharmacotherapy; 2018 Jan; 38(1):19-28. PubMed ID: 29044720
[TBL] [Abstract][Full Text] [Related]
3. Real World Use of Anti-Obesity Medications and Weight Change in Veterans.
Hung A; Wong ES; Dennis PA; Stechuchak KM; Blalock DV; Smith VA; Hoerster K; Vimalananda VG; Raffa SD; Maciejewski ML
J Gen Intern Med; 2024 Mar; 39(4):519-528. PubMed ID: 37962730
[TBL] [Abstract][Full Text] [Related]
4. Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
Watkins S; Toliver JC; Kim N; Whitmire S; Garvey WT
J Manag Care Spec Pharm; 2022 Oct; 28(10):1066-1079. PubMed ID: 35856489
[No Abstract] [Full Text] [Related]
5. Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial.
Pantalone KM; Smolarz BG; Ramasamy A; Baz Hecht M; Harty BJ; Rogen B; Griebeler ML; Borukh E; Young JB; Burguera B
JAMA Netw Open; 2021 Jul; 4(7):e2116595. PubMed ID: 34255049
[TBL] [Abstract][Full Text] [Related]
6. Patient Characteristics Associated with Receipt of Prescription Weight-Management Medications Among Veterans Participating in MOVE!
Thomas DD; Waring ME; Ameli O; Reisman JI; Vimalananda VG
Obesity (Silver Spring); 2019 Jul; 27(7):1168-1176. PubMed ID: 31090207
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Winterholer S; Jeitler K; Horvath K; Berghold A; Krenn C; Semlitsch T
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD007654. PubMed ID: 33454957
[TBL] [Abstract][Full Text] [Related]
8. Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis.
Khera R; Pandey A; Chandar AK; Murad MH; Prokop LJ; Neeland IJ; Berry JD; Camilleri M; Singh S
Gastroenterology; 2018 Apr; 154(5):1309-1319.e7. PubMed ID: 29305933
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of anti-obesity medications approved for long-term use in a multidisciplinary weight management program: a multi-center clinical experience.
Calderon G; Gonzalez-Izundegui D; Shan KL; Garcia-Valencia OA; Cifuentes L; Campos A; Collazo-Clavell ML; Shah M; Hurley DL; Abu Lebdeh HS; Sharma M; Schmitz K; Clark MM; Grothe K; Mundi MS; Camilleri M; Abu Dayyeh BK; Hurtado Andrade MD; Mokadem MA; Acosta A
Int J Obes (Lond); 2022 Mar; 46(3):555-563. PubMed ID: 34811486
[TBL] [Abstract][Full Text] [Related]
10. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S
JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618
[TBL] [Abstract][Full Text] [Related]
11. Diabetes Prevention Program Translation in the Veterans Health Administration.
Moin T; Damschroder LJ; AuYoung M; Maciejewski ML; Datta SK; Weinreb JE; Steinle NI; Billington C; Hughes M; Makki F; Holleman RG; Kim HM; Jeffreys AS; Kinsinger LS; Burns JA; Richardson CR
Am J Prev Med; 2017 Jul; 53(1):70-77. PubMed ID: 28094135
[TBL] [Abstract][Full Text] [Related]
12. Antiobesity medication use across the veterans health administration: patient-level predictors of receipt.
Del Re AC; Frayne SM; Harris AH
Obesity (Silver Spring); 2014 Sep; 22(9):1968-72. PubMed ID: 24931332
[TBL] [Abstract][Full Text] [Related]
13. THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE.
Shibuya K; Ali KF; Ji X; Milinoivh A; Bauman J; Kattan MW; Pantalone KM; Burguera B
Endocr Pract; 2019 Oct; 25(10):1022-1028. PubMed ID: 31241358
[No Abstract] [Full Text] [Related]
14. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Tak YJ; Lee SY
Curr Obes Rep; 2021 Mar; 10(1):14-30. PubMed ID: 33410104
[TBL] [Abstract][Full Text] [Related]
15. A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States.
Nuijten M; Marczewska A; Araujo Torres K; Rasouli B; Perugini M
J Med Econ; 2018 Sep; 21(9):835-844. PubMed ID: 29678127
[TBL] [Abstract][Full Text] [Related]
16. Outcome by Gender in the Veterans Health Administration Motivating Overweight/Obese Veterans Everywhere Weight Management Program.
Batch BC; Goldstein K; Yancy WS; Sanders LL; Danus S; Grambow SC; Bosworth HB
J Womens Health (Larchmt); 2018 Jan; 27(1):32-39. PubMed ID: 28731844
[TBL] [Abstract][Full Text] [Related]
17. Obesity Pharmacotherapy is Effective in the Veterans Affairs Patient Population: A Local and Virtual Cohort Study.
Pendse J; Vallejo-García F; Parziale A; Callanan M; Tenner C; Alemán JO
Obesity (Silver Spring); 2021 Feb; 29(2):308-316. PubMed ID: 33491308
[TBL] [Abstract][Full Text] [Related]
18. MOVE: weight management program across the Veterans Health Administration: patient- and facility-level predictors of utilization.
Del Re AC; Maciejewski ML; Harris AH
BMC Health Serv Res; 2013 Dec; 13():511. PubMed ID: 24325730
[TBL] [Abstract][Full Text] [Related]
19. Real-world primary nonadherence to antiobesity medications.
Kan H; Bae JP; Dunn JP; Buysman EK; Gronroos NN; Swindle JP; Bengtson LGS; Ahmad N
J Manag Care Spec Pharm; 2023 Oct; 29(10):1099-1108. PubMed ID: 37594848
[No Abstract] [Full Text] [Related]
20. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T
Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
